SEB Q1 2026 Earnings Strong EPS Performance Amid Limited Visibility EFOI Q4 2024 Earnings Narrowed Loss Highlights Ongoing Restructuring Efforts APAM Q1 2026 Earnings EPS Miss Highlights Margin Pressure Despite Steady AUM Growth AIM ImmunoTech Q1 2026 Earnings WiderthanExpected Loss on Absence of Revenue LMFA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Company Posts Zero Revenue CVCO Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Gains 36